Status: Recruiting
A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.
A prospective, multicenter, observational cohort study to evaluate the efficacy and safety of a novel anti-tumor drug as a radiosensitizer in patients with advanced breast cancer brain metastasis.
Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesUpdated: Jun 10, 2026Locations: 1Duration: 2 Years
Eligibility criteria
Males or females who are at least 18 years of age on the day of signing the info... [+4]
The subject has leptomeningeal metastasis. [+4]